Literature DB >> 15303839

Small-molecule dimerization inhibitors of wild-type and mutant HIV protease: a focused library approach.

Michael D Shultz1, Young-Wan Ham, Song-Gil Lee, David A Davis, Cara Brown, Jean Chmielewski.   

Abstract

We demonstrate that a focused library based on truncated, cross-linked interfacial peptides of HIV-1 protease produces effective dimerization inhibitors of the enzyme. By combining individual changes of the library into a single compound, we obtained a significantly more potent agent and found that an additive increase in inhibitor efficacy was obtained. The good activity of library members against an active-site drug-resistant protease mutant bodes well for dimerization inhibition as a complementary method to targeting the active site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15303839     DOI: 10.1021/ja048139n

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  10 in total

Review 1.  Targeting protein-protein interactions by rational design: mimicry of protein surfaces.

Authors:  Steven Fletcher; Andrew D Hamilton
Journal:  J R Soc Interface       Date:  2006-04-22       Impact factor: 4.118

Review 2.  Targeting structural flexibility in HIV-1 protease inhibitor binding.

Authors:  Viktor Hornak; Carlos Simmerling
Journal:  Drug Discov Today       Date:  2006-12-20       Impact factor: 7.851

3.  Cross-linked peptoid-based dimerization inhibitors of HIV-1 protease.

Authors:  Song-Gil Lee; Jean Chmielewski
Journal:  Chembiochem       Date:  2010-07-26       Impact factor: 3.164

4.  Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir.

Authors:  Hironori Hayashi; Nobutoki Takamune; Takashi Nirasawa; Manabu Aoki; Yoshihiko Morishita; Debananda Das; Yasuhiro Koh; Arun K Ghosh; Shogo Misumi; Hiroaki Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

5.  Analysis and characterization of dimerization inhibition of a multi-drug-resistant human immunodeficiency virus type 1 protease using a novel size-exclusion chromatographic approach.

Authors:  David A Davis; Irene R Tebbs; Sarah I Daniels; Stephen J Stahl; Joshua D Kaufman; Paul Wingfield; Michael J Bowman; Jean Chmielewski; Robert Yarchoan
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

6.  A multi-drug resistant HIV-1 protease is resistant to the dimerization inhibitory activity of TLF-PafF.

Authors:  Ravikiran S Yedidi; Gheorghe Proteasa; Philip D Martin; Zhigang Liu; John F Vickrey; Iulia A Kovari; Ladislau C Kovari
Journal:  J Mol Graph Model       Date:  2014-07-04       Impact factor: 2.518

7.  Design, synthesis and evaluation of a potent substrate analog inhibitor identified by scanning Ala/Phe mutagenesis, mimicking substrate co-evolution, against multidrug-resistant HIV-1 protease.

Authors:  Ravikiran S Yedidi; Joseck M Muhuhi; Zhigang Liu; Krisztina Z Bencze; Kyriacos Koupparis; Carrie E O'Connor; Iulia A Kovari; Mark R Spaller; Ladislau C Kovari
Journal:  Biochem Biophys Res Commun       Date:  2013-08-03       Impact factor: 3.575

8.  Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy.

Authors:  Hailiu Yang; Joseph Nkeze; Richard Y Zhao
Journal:  Cell Biosci       Date:  2012-09-12       Impact factor: 7.133

9.  Disrupting the Constitutive, Homodimeric Protein-Protein Interface in CK2β Using a Biophysical Fragment-Based Approach.

Authors:  Wei-Guang Seetoh; Chris Abell
Journal:  J Am Chem Soc       Date:  2016-10-20       Impact factor: 15.419

Review 10.  Regulation of enzyme activity through interactions with nanoparticles.

Authors:  Zhaochun Wu; Bin Zhang; Bing Yan
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.